Sprue-like enteropathy associated with olmesartan in a patient with villous atrophy, HLA-DQ2 genotype and antinuclear antibodies

Rev Esp Enferm Dig. 2016 Nov;108(11):732-733.

Abstract

We describe a new case of enteropathy with villous atrophy in a patient suffering from arterial hypertension treated with olmesartan. The molecular and serological studies showed anti-nuclear antibodies (ANA) and haplotype HLA-DQ2 positive, as well as negative results for anti-transglutaminase, anti-endomysium and anti-enterocytes antibodies. A duodenal villous atrophy was suspected by upper gastrointestinal endoscopy, which was confirmed by histopathology. The morphological picture was suggestive of sprue-like enteropathy with severe lymphoid infiltration and predominant T lymphoid cells.

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Antinuclear / immunology*
  • Anticholesteremic Agents / adverse effects*
  • Atrophy
  • Celiac Disease / diagnostic imaging*
  • Gastrointestinal Diseases / chemically induced*
  • Gastrointestinal Diseases / diagnostic imaging*
  • Gastrointestinal Diseases / genetics
  • Genotype
  • HLA-DQ Antigens / genetics*
  • Humans
  • Imidazoles / adverse effects*
  • Male
  • Tetrazoles / adverse effects*

Substances

  • Antibodies, Antinuclear
  • Anticholesteremic Agents
  • HLA-DQ Antigens
  • HLA-DQ2 antigen
  • Imidazoles
  • Tetrazoles
  • olmesartan